Robert W. Ligon, MS

Original Contribution

Bivalirudin versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Drug-Eluting Stent Implantations in the Absence of Acute Myo

08/01/2008

Gregory J. Mishkel , MD, FRCPC, FACC, FSCAI;

Anna L. Moore , MPH;

Stephen J. Markwell , MA, MS;

Robert W. Ligon , MS;

Bare-metal stents (BMS) lower the risk of restenosis and the need for repeat coronary revascularization compared to balloon angioplasty alone.1 The introduction of drug-eluting stents (DES) has further markedly decreased angiographic...

Bare-metal stents (BMS) lower...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Robert W. Ligon, MS

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products